REalloys Q3 update: Army term sheet executed but magnet production slides to 2030, deepening DFARS timeline risk

What happened

In its Q3 2026 filing, REalloys disclosed a term sheet with the U.S. Army for a heavy rare earth processing facility at Tooele Army Depot, a step beyond the conditional partnership announced in June, but the document also outlines magnet production only by 2030, far beyond the January 2027 DFARS deadline used to justify the stock's premium. The update claims advancement in SRC metallization and the Rare Earth Processing Facility programs, yet provides no filing-level evidence of SRC commissioning or conversion of $2.4M in deposits into delivered equipment, which the master report flagged as a key bottleneck. The company continues to burn cash at a rate of roughly $(10)M per quarter, with Q3 financials not detailed beyond a cryptic '$116' reference, raising questions about capital sufficiency despite the previously announced $100M placement. Meanwhile, management's narrative still lacks definitive DFARS-linked orders or named customer qualification acceptance, which were defined as the primary catalysts for re-rating. Overall, the update confirms incremental government engagement but simultaneously stretches the timeline, increasing the risk that the market's near-term compliance story breaks.

Implication

The term sheet with the Army slightly de-risks the Tooele pathway, but it is not an executed EUL or funded notice-to-proceed, and the 2030 magnet production target directly contradicts the near-term DFARS readiness narrative that drives the current valuation. Investors should demand concrete filing evidence of SRC commissioning and deposition conversion in the Q3 10-Q, because without it the company's supply chain remains unverified and the $2.4M deposit pattern may indicate capital being spent without deliverables. The lack of a named DFARS-tied customer order or qualification acceptance by Q4 2026 means the company is missing its own checkpoint, increasing the probability of a credibility reset and downward re-rating. If the ~$100M placement has closed, the company may have runway, but the persistent cash burn and the apparent lack of revenue scale suggest any additional capital needs will likely come at dilutive prices. Thus, the risk/reward remains unfavorable at current levels; existing holders should consider trimming into strength above $18 if possible, while new investors should wait for either a successful SRC commissioning confirmation or a definitive defense order before establishing positions.

Thesis delta

Previously, the thesis hinged on Q4 2026 qualification and a 2027 DFARS compliance window; this update shifts management's stated magnet production to 2030, directly undermining the near-term story. The executed term sheet with the Army is a minor positive, but without SRC commissioning evidence or definitive orders, the core assumption of rapid defense supply remains unproven. Therefore, the rating remains 'Potential Sell,' with downside risk increasing as the company stretches timelines while burning cash.